annual retained earnings:
-$340.52M+$275.19M(+44.69%)Summary
- As of today (June 23, 2025), PTGX annual retained earnings is -$340.52 million, with the most recent change of +$275.19 million (+44.69%) on December 31, 2024.
- During the last 3 years, PTGX annual retained earnings has risen by +$68.84 million (+16.82%).
- PTGX annual retained earnings is now -2611.59% below its all-time high of -$12.56 million, reached on December 31, 2014.
Performance
PTGX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$352.18M-$11.65M(-3.42%)Summary
- As of today (June 23, 2025), PTGX quarterly retained earnings is -$352.18 million, with the most recent change of -$11.65 million (-3.42%) on March 1, 2025.
- Over the past year, PTGX quarterly retained earnings has increased by +$56.19 million (+13.76%).
- PTGX quarterly retained earnings is now -1184.57% below its all-time high of -$27.42 million, reached on December 31, 2015.
Performance
PTGX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PTGX Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.7% | +13.8% |
| 3 y3 years | +16.8% | +18.1% |
| 5 y5 years | -56.5% | -48.1% |
PTGX Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | -3.4% | +45.2% |
| 5 y | 5-year | -56.5% | +44.7% | -48.1% | +45.2% |
| alltime | all time | -2611.6% | +44.7% | -1184.6% | +45.2% |
PTGX Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$352.18M(+3.4%) |
| Dec 2024 | -$340.52M(-44.7%) | -$340.52M(-27.9%) |
| Sep 2024 | - | -$472.20M(+7.6%) |
| Jun 2024 | - | -$438.99M(+7.5%) |
| Mar 2024 | - | -$408.37M(-33.7%) |
| Dec 2023 | -$615.71M(+14.7%) | -$615.71M(-4.3%) |
| Sep 2023 | - | -$643.04M(+5.6%) |
| Jun 2023 | - | -$608.94M(+6.7%) |
| Mar 2023 | - | -$570.48M(+6.3%) |
| Dec 2022 | -$536.75M(+31.1%) | -$536.75M(+6.8%) |
| Sep 2022 | - | -$502.56M(+6.6%) |
| Jun 2022 | - | -$471.33M(+9.5%) |
| Mar 2022 | - | -$430.29M(+5.1%) |
| Dec 2021 | -$409.36M(+44.2%) | -$409.36M(+9.9%) |
| Sep 2021 | - | -$372.45M(+10.0%) |
| Jun 2021 | - | -$338.65M(+10.0%) |
| Mar 2021 | - | -$307.81M(+8.5%) |
| Dec 2020 | -$283.81M | -$283.81M(+7.1%) |
| Sep 2020 | - | -$264.93M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -$257.16M(+8.2%) |
| Mar 2020 | - | -$237.74M(+9.2%) |
| Dec 2019 | -$217.66M(+54.9%) | -$217.66M(+8.7%) |
| Sep 2019 | - | -$200.16M(+8.9%) |
| Jun 2019 | - | -$183.75M(+18.9%) |
| Mar 2019 | - | -$154.58M(+10.0%) |
| Dec 2018 | -$140.47M(+38.3%) | -$140.47M(+11.0%) |
| Sep 2018 | - | -$126.61M(+7.4%) |
| Jun 2018 | - | -$117.87M(+7.9%) |
| Mar 2018 | - | -$109.21M(+7.5%) |
| Dec 2017 | -$101.55M(+57.2%) | -$101.55M(+3.1%) |
| Sep 2017 | - | -$98.50M(+5.2%) |
| Jun 2017 | - | -$93.67M(+19.0%) |
| Mar 2017 | - | -$78.69M(+21.8%) |
| Dec 2016 | -$64.59M(+135.6%) | -$64.59M(+21.1%) |
| Sep 2016 | - | -$53.34M(+15.3%) |
| Jun 2016 | - | -$46.26M(+18.1%) |
| Mar 2016 | - | -$39.16M(+42.8%) |
| Dec 2015 | -$27.42M(+118.3%) | -$27.42M |
| Dec 2014 | -$12.56M | - |
FAQ
- What is Protagonist Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual retained earnings year-on-year change?
- What is Protagonist Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
What is Protagonist Therapeutics annual retained earnings?
The current annual retained earnings of PTGX is -$340.52M
What is the all time high annual retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual retained earnings is -$12.56M
What is Protagonist Therapeutics annual retained earnings year-on-year change?
Over the past year, PTGX annual retained earnings has changed by +$275.19M (+44.69%)
What is Protagonist Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PTGX is -$352.18M
What is the all time high quarterly retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly retained earnings is -$27.42M
What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PTGX quarterly retained earnings has changed by +$56.19M (+13.76%)